94 related articles for article (PubMed ID: 25980590)
1. An insight into antagonist binding and induced conformational dynamics of class B GPCR corticotropin-releasing factor receptor 1.
Xu J; Wang Z; Liu P; Li D; Lin J
Mol Biosyst; 2015 Jul; 11(7):2042-50. PubMed ID: 25980590
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the antagonist CP-376395 escape pathway for the corticotropin-releasing factor receptor 1 by random acceleration molecular dynamics simulations.
Bai Q; Shi D; Zhang Y; Liu H; Yao X
Mol Biosyst; 2014 Jul; 10(7):1958-67. PubMed ID: 24820411
[TBL] [Abstract][Full Text] [Related]
3. Antagonist binding and induced conformational dynamics of GPCR A2A adenosine receptor.
Pang X; Yang M; Han K
Proteins; 2013 Aug; 81(8):1399-410. PubMed ID: 23508898
[TBL] [Abstract][Full Text] [Related]
4. Residues remote from the binding pocket control the antagonist selectivity towards the corticotropin-releasing factor receptor-1.
Sun X; Cheng J; Wang X; Tang Y; Ågren H; Tu Y
Sci Rep; 2015 Jan; 5():8066. PubMed ID: 25628267
[TBL] [Abstract][Full Text] [Related]
5. Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures.
Dore AS; Bortolato A; Hollenstein K; Cheng RKY; Read RJ; Marshall FH
Curr Mol Pharmacol; 2017; 10(4):334-344. PubMed ID: 28183242
[TBL] [Abstract][Full Text] [Related]
6. Activation of corticotropin-releasing factor 1 receptor: insights from molecular dynamics simulations.
Singh R; Ahalawat N; Murarka RK
J Phys Chem B; 2015 Feb; 119(7):2806-17. PubMed ID: 25607803
[TBL] [Abstract][Full Text] [Related]
7. Conformational thermostabilisation of corticotropin releasing factor receptor 1.
Kean J; Bortolato A; Hollenstein K; Marshall FH; Jazayeri A
Sci Rep; 2015 Jul; 5():11954. PubMed ID: 26159865
[TBL] [Abstract][Full Text] [Related]
8. In silico binding mechanism prediction of benzimidazole based corticotropin releasing factor-1 receptor antagonists by quantitative structure activity relationship, molecular docking and pharmacokinetic parameters calculation.
Kumar N; Mishra SS; Sharma CS; Singh HP; Kalra S
J Biomol Struct Dyn; 2018 May; 36(7):1691-1712. PubMed ID: 28521603
[TBL] [Abstract][Full Text] [Related]
9. Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells.
Seidel L; Zarzycka B; Zaidi SA; Katritch V; Coin I
Elife; 2017 Aug; 6():. PubMed ID: 28771403
[TBL] [Abstract][Full Text] [Related]
10. Structural-functional analysis of the third transmembrane domain of the corticotropin-releasing factor type 1 receptor: role in activation and allosteric antagonism.
Spyridaki K; Matsoukas MT; Cordomi A; Gkountelias K; Papadokostaki M; Mavromoustakos T; Logothetis DE; Margioris AN; Pardo L; Liapakis G
J Biol Chem; 2014 Jul; 289(27):18966-77. PubMed ID: 24838244
[TBL] [Abstract][Full Text] [Related]
11. Structure of class B GPCR corticotropin-releasing factor receptor 1.
Hollenstein K; Kean J; Bortolato A; Cheng RK; Doré AS; Jazayeri A; Cooke RM; Weir M; Marshall FH
Nature; 2013 Jul; 499(7459):438-43. PubMed ID: 23863939
[TBL] [Abstract][Full Text] [Related]
12. Activation Mechanism of Corticotrophin Releasing Factor Receptor Type 1 Elucidated Using Molecular Dynamics Simulations.
Uba AI; Scorese N; Dean E; Liu H; Wu C
ACS Chem Neurosci; 2021 May; 12(9):1674-1687. PubMed ID: 33860667
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential antagonists of CRF1R for possible treatment of stress and anxiety neuro-disorders using structure-based virtual screening and molecular dynamics simulation.
Uba AI; Wu C
Comput Biol Chem; 2022 Oct; 100():107743. PubMed ID: 35926444
[TBL] [Abstract][Full Text] [Related]
14. 2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy.
Dubowchik GM; Michne JA; Zuev D; Schwartz W; Scola PM; James CA; Ruediger EH; Pin SS; Burris KD; Balanda LA; Gao Q; Wu D; Fung L; Fiedler T; Browman KE; Taber MT; Zhang J
Bioorg Med Chem Lett; 2003 Nov; 13(22):3997-4000. PubMed ID: 14592493
[TBL] [Abstract][Full Text] [Related]
15. Understanding Corticotropin Releasing Factor Receptor (CRFR) Activation Using Structural Models.
Cordomi A; Liapakis G; Matsoukas MT
Curr Mol Pharmacol; 2017; 10(4):325-333. PubMed ID: 28103783
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference.
Lasheras MC; Laorden ML; Milanés MV; Núñez C
Neuropharmacology; 2015 Aug; 95():168-80. PubMed ID: 25556110
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a stable tripeptide targeting the N-domain of CRF1 receptor.
Liapakis G; Karageorgos V; Andreadelis I; Holz GG; Dermitzaki E; Kordopati GG; Stylos EΚ; Spyridaki K; Poulaki S; Ntountaniotis D; Sakellaris S; Vanioti M; Kostagianni A; Marousis KD; Leonis G; Kokotos G; Venihaki M; Spyroulias GA; Tselios T; Margioris A; Tzakos AG; Mavromoustakos T
Amino Acids; 2020 Sep; 52(9):1337-1351. PubMed ID: 32996057
[TBL] [Abstract][Full Text] [Related]
19. Optimization of CRF1R binding affinity of 2-(2,4,6-trichlorophenyl)-4-trifluoromethyl-5-aminomethylthiazoles through rapid and selective parallel synthesis.
Zuev D; Michne JA; Pin SS; Zhang J; Taber MT; Dubowchik GM
Bioorg Med Chem Lett; 2005 Jan; 15(2):431-4. PubMed ID: 15603967
[TBL] [Abstract][Full Text] [Related]
20. Selective antagonism of CRF1 receptor by a substituted pyrimidine.
Sakellaris S; Matsoukas MT; Karageorgos V; Poulaki S; Kuppast B; Margioris A; Venihaki M; Fahmy H; Liapakis G
Hormones (Athens); 2019 Jun; 18(2):215-221. PubMed ID: 30980254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
